Miniaturized Dissolution Testing
Miniaturized Dissolution Testing is a specialized dissolution methodology within biorelevant dissolution testing that employs scaled-down apparatus and reduced sample volumes to enable high-throughput, resource-efficient evaluation of drug release profiles while maintaining physiological relevance.
38
Publications
1.1K
Citations
144
Authors
54
Institutions
Publications per year
2017–2026
8
38
Anant Shanbhag, Shelley R. Rabel, Ewa Nauka et al. · International Journal of Pharmaceutics · 2007 · 85 citations
1–5 of 38
144
3
h-index
2
h-index
2
h-index
Merck & Co., Inc., Rahway, NJ, USA (United States), United States
2 publications · 37 citations
2
h-index
2
h-index
1–5 of 144
54
New Jersey Institute of Technology
Newark, United States
3 h-index
6 publications
110 citations

University of Southern Denmark
Odense, Denmark
2 h-index
8 publications
248 citations
Boehringer Ingelheim (Germany)
Ingelheim, Germany
2 h-index
9 publications
383 citations
Roche (Switzerland)
Basel, Switzerland
2 h-index
8 publications
286 citations

University of Strathclyde
Glasgow, United Kingdom
2 h-index
3 publications
106 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
2 h-index
2 publications
37 citations
University of Pittsburgh
Pittsburgh, United States
1 h-index
9 publications
171 citations
Magee-Womens Research Institute
Pittsburgh, United States
1 h-index
3 publications
57 citations
1–8 of 54
9 publications · 218 citations
9
h-index
8 publications · 170 citations
8
h-index
4 publications · 150 citations
5
h-index
5 publications · 179 citations
5
h-index
3 publications · 73 citations
3
h-index
1–5